ARCHIVES

More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications

This article is from The Cancer Letter archive.

Vol. 10 No. 08 | February 24, 1984

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Recompetition Of Two Major Contracts

October 30, 1987

New CCP Lineup remains Unclear; 11 Bases OK’d

April 5, 1991

Genetic Testing: No Easy Answers To Public Questions

May 15, 1998

Cancer Meetings Listed

March 26, 1993

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008